Myelodysplastic neoplasms (MDS)
- Myelodysplastic syndromes
Tag: Myelodysplastic syndromes
Quest to better understand MDS and find out more effective therapies
When someone with MDS is treated with azacitidine (Vidaza®), it takes six months to find out if they are responding to the drug. Dr Unnikrishnan is working to change that.
- Myelodysplastic syndromes
- Research
Merrick from Berwick has “reported for duty” since 2012
For almost eight years, this has been Brian Merrick’s greeting when entering the treatment room in Melbourne for his monthly round of azacitidine (Vidaza®) injections on a clinical trial.
- Myelodysplastic syndromes
Stepping up to the challenge of curing MDS
Louise thought it was her busy job that was making her tired, when she received a shock MDS diagnosis.
- Myelodysplastic syndromes
Searching for biomarkers and better treatments for B-cell lymphomas
Professor Ricky Johnstone hopes to find new research treatments for B-cell lymphomas.
- Acute myeloid leukaemia
- Myelodysplastic syndromes
- Myeloproliferative neoplasms
Talking myelodysplastic syndrome with Dr Melita Kenealy
From current treatments to living with the disease, Dr Melita Kenealy covers the basics of MDS.
- Myelodysplastic syndromes
Improving the “wait and see” approach to treatment for high-risk blood cancer
Researchers have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment.
- Myelodysplastic syndromes
- Research
